Company / Gross Profit
PLUS THERAPEUTICS, INC. Gross Profit History
FY2011-FY2017 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Gross Profit
$1.9M
FY2017
5-year range
$1.7M / $1.9M
FY2013-FY2017
Trend
+17.5%
vs FY2016
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Gross Profit returned to growth in FY2017 after 2 years of decline, reaching $2M.
Based on SEC 10-K filings.
$2M in FY2017 with a 5-year CAGR of -14.9%.
Declined from $4M to $2M over the past 2 years.
Gross Profit over time
Growth rates
- 3-Year CAGR
- -25.6%
- 5-Year CAGR
- -14.9%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of -14.9%, indicating a declining trend.
- In FY2017, gross profit increased 17.5% year-over-year.
- Peak gross profit was recorded in FY2014.
- Lowest gross profit in the period was in FY2016.
Company context
Key Data Points
- Altman Z-Score -2.46 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Gross ProfitValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | - | - |
| FY2018 | - | - |
| FY2017 | $1.9M | +17.5% |
| FY2016 | $1.7M | -55.4% |
| FY2015 | $3.7M | -21.4% |
| FY2014 | $4.7M | +13.6% |
| FY2013 | $4.1M | -4.6% |
| FY2012 | $4.3M | +77.9% |
| FY2011 | $2.4M | - |
As of FY2017 · SEC 10-K · Updated Jun 28, 2026